Consent to participate Written informed consents were received from participants or their guardians upon explanation of the study
Early studies suggest that retatrutide and tirzepatide (Mounjaro) may work better than semaglutide for weight loss, with both showing higher percentages of body weight reduction in clinical trials
It acts locally in the colon, minimizing the risks often seen with traditional drugs
SUSTAIN 7 is a phase 3b, 40-week, efficacy and safety trial of 0.5 mg semaglutide versus 0.75 mg dulaglutide and 1.0 mg semaglutide versus 1.5 mg dulaglutide, both once-weekly, as add-on to metformin in 1201 people with T2DM
These liposomes encapsulate and protect the CoQ10 molecules that help facilitate a more efficient transition through the digestive system and are absorbed more readily into the bloodstream
Highly specific epigenome editing by CRISPRCas9 repressors for silencing of distal regulatory elements